3 Chi J Intl L 87
Obijiofor Aginam

This article explores the malaria control strategies of multilateral institutions, especially the World Health Organization (WHO). It argues that traditional therapies in malaria endemic societies in the developing world are yet to form part of the core multilateral malaria regime. It discusses the vision of the WHO's Roll-Back Malaria Campaign (RBM): an innovative private-public partnership aimed at reducing the mortality and morbidity burdens of malaria in the developing world. The article raises questions of accountability and transparency of the operational framework of global partnerships such as the RBM. While such partnerships have emerged as innovative mechanisms in global health governance, the search for a cosmopolitan and inclusive malaria regime must strive to identify all the relevant stakeholders and actors: populations that live in communities where malaria is endemic as well as the traditional therapies used by those populations, civil society, national governments, multilateral health organizations, and pharmaceutical companies. The article draws from extended field interviews, which the author conducted in rural populations in Nigeria. It concludes that a sustained relegation of traditional medicine to the peripheries of multilateral malaria regime is one form of "globalism-from-above" that projects the phenomenon of multilateralism as intensely hegemonic and predatory.